Type 2 polyglandular autoimmune disease (Schmidt's syndrome)

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue SUPPL. 1, 1996, Pages 113-123

  Betterle, C ^a   Volpato, M ^a   Greggio, A N ^a   Presotto, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL DISEASE; AUTOIMMUNITY; CHILDHOOD DISEASE; CONFERENCE PAPER; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; NONHUMAN; PREVALENCE; SCHMIDT SYNDROME; SYMPTOMATOLOGY;

EID: 0029968793     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.1996.9.s1.113     Document Type: Conference Paper

References (51)

1. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14. 426-430.
2. Neufeld M, Blizzard RM. Polyglandular autoimmune disease. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L, eds. Symposium on Autoimmune Aspects of Endocrine Disorders. New York. Academic Press, 1980; 357-365.
3. Ogle JW. Brain disease from diabetes mellitus. St George's Hosp Rep 1866; 1. 178.
4. Schmidt MB. Eine biglandulare Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 1926; 21: 212-221.
5. Susman W. Atrophy of adrenals associated with Addison's disease. J Path Bact 1930; 33: 749-755.
6. Rowntree LG, Snell AM. A clinical study of Addison's disease. In: Mayo Clinic Monographs. Philadelphia, PA. W.B. Saunders Co., 1931.
7. Gowen WM. Addison's disease with diabetes mellitus. N Engl J Med 1932; 207: 577-581.
8. Bloodworth JMB, Kirkendall WM, Carr TL Addison's disease associated with thyroid insufficiency and atrophy. J Clin Endocrinol 1954; 14: 540-545.
9. Anderson JR, Goudie RB, Gray KG, Timbary GC. Autoantibodies in Addison's disease. Lancet 1957; 1: 1123-1124.
10. Carpenter CCJ., Solomon N, Silverberg SG, Bledsoe T, Northcutt RC, Klinenberg JR, Bennett IL, McGehee Harvey A. Schmidt's syndrome (thyroid and adrenal insufficiency): a review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine 1964, 43: 153-180.
11. Khoury-EL, Bottazzo GF, Pontes de Carvalho LC, Wick G, Roitt IM Predisposition to organ-specific autoimmunity in obese strain (OS) chickens: reactivity to thyroid, gastric, adrenal and pancreatic cytoplasmic antigens. Clin Exp Immunol 1982; 49: 273-282.
12. Bartholomaeus WN, O'Donoghue H, Foti D, Lawson CM, Shellam GR, Reed WD. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 1988; 64. 397-405
13. Sakaguchi S, Sakaguchi N Organ-specific autoimmune disease induced in mice by elimination of T cell subsets J Immunol 1989; 142: 471-480.
14. Stuart-Mason A, Meade TW, Lee JAH, Morris JN Epidemiological and clinical picture of Addison's disease. Lancet 1968, 2: 744-747.
15. Papadopoulos IK, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease Acta Endocrinol 1990, 122: 472-478.
16. Weetman AP. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmumty. Bailliere's Clin Endocrinol Metab 1995; 9: 157-174.
17. Doniach D, Bottazzo GF, Polyendocrine autoimmunity. In: Franklin EC, ed. Clinical Immunology Update. Amsterdam: Elsevier North Holland, 1981; 95-121.
18. Eisenbarth GS, Jackson RA. Immunogenetics of polyglandular failure and related diseases. In. Farid NR, ed. HLA in Endocrine and Metabolic Disorders. New York Academic Press, 1981; 235-264
19. Trence DL, Morley JE Polyglandular autoimmune syndromes. Am J Med 1984; 77: 107-116.
20. Maclaren NK, Blizzard RM. Adrenal autoimmumty and autoimmune polyglandular syndromes. In: Rose NR, MacKay IR, eds. The Autoimmune Disease London: Academic Press, 1985; 202-224
21. Meyerson J, Lechuga-Gomez EE, Bigazzi PE, Walfish PG. Polyglandular autoimmune syndrome, current concepts. Can Med Assoc J 1988; 138: 605-612.
22. Betterle C, Scalici C, Pedini B, Mantero F. Morbo di Addison: principali associazioni cliniche e descrizione della storia naturale della malattia. Ann Ital Med Int 1989; 4: 195-206.
23. Muir A, Maclaren NK. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. Endrocrinol Metab Clin N Am 1991; 20: 619-644
24. Riley WJ. Autoimmune polyglandular syndromes Horm Res 1992, 38 (Suppl 2): 9-15.
25. Betterle C, Pedini B, Presotto F. Serological markers in Addison's disease. In. Bhatt R, James VHT, Besser M, Bottazzo GF, Keen H, eds. Advances in Thomas Addison's Diseases. Bristol: J Endocrinol Ltd., 1994, 2: 67-84.
26. Spinner M, Blizzard R, Childs B. Clinical and genetic heterogeneity in idopathic Addison's disease and hypoparathyroidism. J Clin Endocrinol Metab 1968; 28: 795-804.
27. Anderson PB, Seymour HF, Frey G. Familial Schmidt's syndrome. JAMA 1980, 244: 2068-2070
28. Skordis N, Maclaren N. Immunogenetics of autoimmune polyglandular syndromes. In: Farid NR, ed Immunogenetics of Endocrine Disorders. New York: A.R. Liss Inc., 1988; 373-399.
29. Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigen-DR3 and/or DR4, except when associated with type 1 autoimmune polyendocrine syndrome J Clin Endocrinol Metab 1986; 62: 455-459
30. Weetman AP, Zhang L, Tandon N, Edwards OM HLA associations with autoimmune Addison's disease. Tissue Antigen 1991; 38: 31-33.
31. Böehm BO, Maufras B, Seidl S, Holzberger G, Kuhnl P, Rosak C, Schoffling K, Trucco M. The HLA-DQbeta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens 1991, 37: 130-132.
32. Betterle C, Rossi A, Dalla Pria S, Artifoni L, Pedini B, Gavasso S, Caretto A Autoimmunity in premature ovarian failure Clin Endocrinol 1993; 39: 35-45.
33. Winqvist O, Karlsson FA, Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992, 339: 1559-1562.
34. Baumann-Antczak A, Wedlock N, Bednarek J, Kiso Y, Krishnan H, Fowler S, Rees Smith B, Furmaniak J. Autoimmune Addison's disease and 21-hydroxylase. Lancet 1992; 340: 429-430
35. Bednarek J, Furmaniak J, Rees Smith B Wedlock N, Kiso Y, Baumann-Antczak A, Fowler S, Krishnan H, Craft JA, Rees Smith B. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett 1992; 309: 51-55.
36. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17alpha-hydroxylase. Lancet 1992; 339: 770-773.
37. Uibo R, Perheentupa J, Ovod V, Krohn KJE. Characterization of adrenal autoantigen recognized by serum of patients with autoimmune polyglandular syndrome (APS) type 1. J Autoimmunity 1994, 7: 399-411.
38. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJE. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994; 78: 323-328.
39. Caforio ALP, Wagner R, Gill JS, Bonifacio E, Bosi E, Miles A, McKenna WJ, Bottazzo GF. Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathy. Lancet 1991; 337 1111-1115.
40. Topliss D, How J, Lewis M, Lewis, Row V, Volpé R. Evidence for cell-mediated immunity and specific suppressor T-lymphocyte dysfunction in Graves' disease and in diabetes mellitus. J Clin Endocrinol Metab 1983, 57: 700-705.
41. Edmonds M, Lamki L, Killinger DW, Volpé R Autoimmune thyroiditis, adrenalitis and oophoritis. Am J Med 1973; 54 782-787.
42. Tomer Y, Davies TF Infections and autoimmune endocrine disease. Baillière's Clin Endocrinol Metab 1995; 9: 47-70.
43. Onodera T, Toniolo A, Ray UR, Bennett-Johnson A, Knazen RA, Notkins AL. Virus-induced diabetes mellitus. Polyendocrinopathy and autoimmunity. J Exp Med 1981, 153: 1457-1473.
44. Haspel MV, Onodera T, Prabhakar BS, Horita M, Suzuki H, Notkins AL Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 1983; 220: 304-306.
45. Tadmor B, Putterman C, Naparstek Y. Embryonal germ-layer antigens: target for autoimmunity. Lancet 1992; 339: 975-978.
46. Colls J, Betterle C, Volpato M, Prentice L, Rees Smith B, Furmaniak J. Autoimmune adrenal disease. A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase Clin Chem 1995; 41: 375-380.
47. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J. Autoantibodies to steroidogenic enzymes in type I and type II autoimmune polyglandular syndrome, isolated Addison's disease and in premature ovarian failure. J Clin Endocrinol Metab 1996; in press.
48. Betterle C, Presotto F, Volpato M, Pedini B. The natural history of Addison's disease in organ-specific autoimmune patients with adrenal cortex antibodies Immunological study. In: Bhatt R, James VHT, Besser M, Bottazzo GF, Keen H, eds. Advances in Thomas Addison's Diseases. Bristol J Endocrinol Ltd., 1994, 1: 51-58.
49. Betterle C, Callegari G, Presotto F, Zanette F, Pedini B, Rampazzo T, Slack RS, Girelli ME, Busnardo B Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis. Acta Endocrinol (Copenhagen) 1987, 114: 321-327.
50. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, Mantero F. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988; 117: 467-475.
51. Betterle C, Presotto F, Magrin L, Pedini B, Moro L, Caretto A, Zanchetta R. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases. Diabetologia 1994; 37: 95-103.